SPO Medical launches pulse oximetry system with European language
7 July 2008
SPO Medical Inc. (SPOM) has released its PulseOx 7500 pulse oximetry
system with support for a graphical user interface and report generation
in multiple languages, including French, Italian, German and Spanish
(FIGS) along with English.
The company believes that by supporting FIGS languages it will be
able to address the growing interest in the system across European
markets and the Spanish-speaking markets of the Americas.
Sleep apnea is a sleep disorder characterized by pauses in breathing
during sleep. Each episode, called apneas, lasts long enough so that one
or more breaths are missed, and occurs repeatedly throughout sleep,
disturbing a person's sleep pattern.
Symptoms may be present for years, even decades without
identification, during which time the sufferer may become conditioned to
the daytime sleepiness and fatigue associated with significant levels of
sleep disturbance. Such fatigue is known to be the cause of road
accidents, industrial accidents and reduction in performance at the work
Typically, people with sleep disorder symptoms are referred by their
primary care physician to third-party sleep clinics for overnight
monitoring at the clinic facility, and depending on the diagnosis, are
prescribed an appropriate medical remedy.
The PulseOx 7500 enables doctors and other medical professionals to
monitor patients from the convenience of the patient's home. Data is
collected and stored overnight by wearing the PulseOx 7500 wrist-watch
configuration while the user sleeps. The next morning, the data is
easily downloaded by the family care or general practitioner for
analysis using supplied reporting software.
"We are delivering this new product feature as a direct result of
increased demand from our European sales distributors. Those caring for
sleep apnea sufferers recognize the value proposition of the PulseOx
7500 and our cost-effective product is now available to a wider
multi-language community as an effective pre-screening device for
detecting sleep disorders in the comfort of a patient's home," commented
Michael Braunold, President and CEO of SPO Medical.